Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
5,26 USD | -0,94 % | -1,31 % | -22,53 % |
Resumen de negocios
Número de empleados: 107
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biologics and Drug Delivery - Services and License
47,8
%
| 5 | 26,4 % | 11 | 47,8 % | +110,83 % |
Functional Neurosurgery Navigation and Therapy - Disposable Products
31,7
%
| 8 | 36,9 % | 8 | 31,7 % | +0,03 % |
Biologics and Drug Delivery - Disposable Products
9,0
%
| 4 | 18,0 % | 2 | 9,0 % | -41,63 % |
Capital Equipment and Software - Services
4,1
%
| 1 | 3,9 % | 1 | 4,1 % | +22,39 % |
Functional Neurosurgery Navigation and Therapy - Services
3,9
%
| 2 | 7,5 % | 1 | 3,9 % | -39,43 % |
Capital Equipment and Software - Systems and Software Products
3,6
%
| 2 | 7,4 % | 1 | 3,6 % | -43,12 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 24 | 100,0 % | +16,56 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07/11/17 |
Director of Finance/CFO | 39 | 29/09/20 | |
Mazin Sabra
COO | Chief Operating Officer | 44 | 10/10/22 |
Caroline Corner
IRC | Investor Relations Contact | - | - |
Jeremy Stigall
PRN | Corporate Officer/Principal | 41 | 01/07/20 |
General Counsel | - | 05/04/21 | |
Sales & Marketing | - | 01/11/19 | |
General Counsel | - | - | |
Robert Korn
SAM | Sales & Marketing | 58 | 12/11/12 |
Chris Yelley
PRN | Corporate Officer/Principal | - | 01/01/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
B. Johnson
BRD | Director/Board Member | 72 | 01/09/19 |
Lynnette Fallon
BRD | Director/Board Member | 64 | 15/07/21 |
R. Fletcher
CHM | Chairman | 78 | 09/05/17 |
Pascal Girin
BRD | Director/Board Member | 64 | 03/09/14 |
Timothy Richards
BRD | Director/Board Member | 66 | 10/03/14 |
Joseph Burnett
CEO | Chief Executive Officer | 47 | 07/11/17 |
Matthew Klein
BRD | Director/Board Member | 52 | 16/04/20 |
Linda Liau
BRD | Director/Board Member | 57 | 02/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 27 069 568 | 25 012 797 ( 92,40 %) | 0 | 92,40 % |
Información de la empresa
Clearpoint Neuro, Inc.
120 South Sierra Avenue Suite 100
92075, Solana Beach
+
http://www.clearpointneuro.comSector
Ventas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-22,53 % | 142 M | |
+8,07 % | 219 mil M | |
+6,59 % | 183 mil M | |
+11,26 % | 133 mil M | |
+26,57 % | 108 mil M | |
+0,65 % | 63,06 mil M | |
+13,35 % | 52,02 mil M | |
-0,62 % | 48,2 mil M | |
-0,93 % | 40,37 mil M | |
+11,54 % | 39,35 mil M |
- Bolsa de valores
- Acciones
- Acción CLPT
- Empresa ClearPoint Neuro, Inc.